2007 ESH/ESC Guidelines for the Management of Arterial Hypertension - what’s new? Attempt of commentary on changes and their validity

Andrzej Tykarski, Tomasz Grodzicki

Editorial

PDF

Early diagnosis of diastolic left ventricular dysfunction in patients with primary hypertension based on seismocardiography

Iwona Korzeniowska-Kubacka, Elżbieta Florczak, Anna Klisiewicz, Ryszard Piotrowicz, Andrzej Januszewicz, Piotr Hoffman

Original paper

PDF

The evaluation of renin-angiotensin-aldosterone system blocking drugs use in hemodialysed patients

Paweł Stróżecki, Mariusz Flisiński, Andrzej Brymora, Robert Kurowski, Witold Doroszewski, Grażyna Zarzycka-Lindner, Agnieszka Oręziak, Jacek Manitius

Original paper

PDF

Effect of telemonitoring of blood pressure in patients with hypertension

Marek Rajzer, Małgorzata Brzozowska-Kiszka, Grzegorz Bilo, Wiktoria Wojciechowska, Kalina Kawecka-Jaszcz

Original paper

PDF

Hypotensive efficacy of eprosartan in postmenopausal women

Joanna Niegowska, Magdalena Niegowska, Bogdan Jasiński

Original paper

PDF

The impact of carotid intima - media complex index selection for the investigation of a correlation with chosen cardiovascular risk factors

Katarzyna Kunicka, Leszek Bieniaszewski, Ewa Świerblewska, Hanna Świątek, Przybysława Kaczmarek-Kusznierewicz, Piotr Kruszewski, Jolanta Neubauer-Geryk, Eliza Miszkowska, Edyta Drzazga

Original paper

PDF

History of hypertension

Włodzimierz Januszewicz, Andrzej Januszewicz, Aleksander Prejbisz

Review paper

PDF

The renin-angiotensin-aldosterone system - new pathogenetic and therapeutic aspects Part 2. Aldosterone - important inductor of pathogenetic pathways damaging the cardiovascular system and kidneys

Lidia Hyla-Klekot, Barbara Pulcer, Franciszek Kokot

Review paper

PDF

Effectiveness comparison of treatment with telmisartan, ramipril and these two drugs combination therapy in reduction of cardiovascular events in high risk patients - ONTARGET/TRANSCEND Study

Ludwina Szczepaniak-Chicheł

PDF

Comparison of two antiplatelet treatment strategies (combination of dipyridamole MR and acetylsalicylic acid vs. clopidogrel) and telmisartan therapy vs. placebo in post-stroke patients in prevention of further cerebrovascular event - PRoFESS Study assumptions

Ludwina Szczepaniak-Chicheł

PDF

ONTARGET/TRANSCEND/PRoFESS - trzy okręty flagowe telmisartanu - komentarz

Krzysztof J. Filipiak

PDF